【town and country insurance norfolk ne】Should Value Investors Consider Dycom (DY) Stock Now?
Value investing is town and country insurance norfolk neeasily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value? One way to find these companies is by looking at several key metrics and financial ratios, many of which are crucial in the value stock selection process. Let’s put Dycom Industries, Inc. DY stock into this equation and find out if it is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks: PE Ratio A key metric that value investors always look at is the Price to Earnings Ratio, or PE for short. This shows us how much investors are willing to pay for each dollar of earnings in a given stock, and is easily one of the most popular financial ratios in the world. The best use of the PE ratio is to compare the stock’s current PE ratio with: a) where this ratio has been in the past; b) how it compares to the average for the industry/sector; and c) how it compares to the market as a whole. On this front, Dycom has a trailing twelve months PE ratio of 10.66, as you can see in the chart below: This level actually compares pretty favorably with the market at large, as the PE for the S&P 500 stands at about 19.47. If we focus on the long-term PE trend, Dycom’s current PE level puts it below its midpoint over the past five years. Moreover, the current level is fairly below the highs for this stock, suggesting it might be a good entry point. Further, the stock’s PE also compares favorably with the industry’s trailing twelve months PE ratio, which stands at 13.70. At the very least, this indicates that the stock is relatively undervalued right now, compared to its peers. However, we should point out that Dycom has a forward PE ratio (price relative to this year’s earnings) of 12.29, so we might say that the forward earnings estimates indicate that the company’s share price will likely appreciate in the near future. P/S Ratio Another key metric to note is the Price/Sales ratio. This approach compares a given stock’s price to its total sales, where a lower reading is generally considered better. Some people like this metric more than other value-focused ones because it looks at sales, something that is far harder to manipulate with accounting tricks than earnings. Right now, Dycom has a P/S ratio of about 0.23. This is significantly lower than the S&P 500 average, which comes in at 3.37 right now. Also, as we can see in the chart below, this is well below the highs for this stock in particular over the past few years. Story continues If anything, DY is in the lower end of its range in the time period from a P/S metric, suggesting some level of undervalued trading—at least compared to historical norms. Broad Value Outlook In aggregate, Dycom currently has a Zacks Value Style Score of B, putting it into the top 40% of all stocks we cover from this look. This makes Dycom a solid choice for value investors, and some of its other key metrics make this pretty clear too. For example, its P/CF ratio (another great indicator of value) comes in at 2.86, which is far better than the industry average of 6.16. Clearly, DY is a solid choice on the value front from multiple angles. What About the Stock Overall? Though Dycom might be a good choice for value investors, there are plenty of other factors to consider before investing in this name. In particular, it is worth noting that the company has a Growth grade of F and a Momentum score of F. This gives DY a Zacks VGM score—or its overarching fundamental grade—of D. (You can read more about the Zacks Style Scores here >>) Meanwhile, the company’s recent earnings estimates have been trending lower. The current fiscal quarter has seen no estimates go higher in the past sixty days compared to one lower, while the fiscal full year estimate has seen zero upward and five downward revisions in the same time period. As a result, the current fiscal quarter consensus estimate has fallen by 86.7% in the past two months, while the fiscal full year estimate has declined 25.9%. You can see the consensus estimate trend and recent price action for the stock in the chart below: Dycom Industries, Inc. Price and Consensus Dycom Industries, Inc. Price and Consensus Dycom Industries, Inc. price-consensus-chart | Dycom Industries, Inc. Quote This negative trend is why the stock has just a Zacks Rank #3 (Hold) despite strong value metrics and why we are looking for in-line performance from the company in the near term. Bottom Line Dycom is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front. However, with a sluggish industry rank (among the bottom 20%) and a Zacks Rank #3, it is hard to get too excited about this company overall. In fact, over the past two years, the industry has clearly underperformed the broader market, as you can see below: So, value investors might want to wait for estimates, analyst sentiment and broader factors to turn around in this name first, but once that happens, this stock could be a compelling pick. Biggest Tech Breakthrough in a Generation Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity. A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time. See 8 breakthrough stocks now>> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Dycom Industries, Inc. (DY) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research View comments
相关推荐
-
Warren calls out Sanders for supporters' ‘really ugly’ online attacks
-
Grocery shopping tips for avoiding coronavirus
-
Looking for a Growth Stock? 3 Reasons Why Lumentum (LITE) is a Solid Choice
-
Trust Stamp Prepares to Pursue Direct Public Listing on Euronext Growth Market
-
Exxe Group Inc. Announces Public Spin-off Strategy to Create Value for Shareholders
-
How Are PlayStation 5, Xbox Poised Before Launch?
- 最近发表
-
- Zuora's (ZUO) Loss Narrows in Q1, Revenues Increase Y/Y
- NextEra Energy (NEE) Stock Moves -1.57%: What You Should Know
- The New America High Income Fund, Inc. Declares Dividend
- Barr Finds No Election Fraud as DOJ Pursues ‘Bribery for Pardons’ Scheme
- Is MYR Group (MYRG) a Great Value Stock Right Now?
- Biden Holds onto a Winning Margin in the Polls after the 1st Debate
- 4 Top Momentum Stocks Powered by Driehaus Strategy
- Brazil manufacturing PMI rises to 38.3 in May from record low 36.0 in April - IHS Markit
- ProPetro Holding (PUMP) Reports Q3 Loss, Lags Revenue Estimates
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mesa Air Group, Inc. - MESA
- 随机阅读
-
- Genius Brands International Promotes Michael Jaffa to Chief Operating Officer
- Comcast Stock Rises 3%
- Understated Factors To Consider Before Investing In Esquire Financial Holdings, Inc. (NASDAQ:ESQ)
- ServiceNow (NOW) Set to Acquire AI-Focused Startup Element AI
- Visa's (V) Program to Aid Asia Pacific Startups Thrive Globally
- The Returns At Treatt (LON:TET) Provide Us With Signs Of What's To Come
- Sherwin-Williams (SHW): Strong Growth And Abundant Potential
- Antibodies, Protein-based Vaccines, Anti-virals, and Cell-based Therapies to Lead the Development of COVID-19 Treatment Pipeline- Exclusive Report by Meticulous Research®
- AstraZeneca to Ensure Equal Access to Coronavirus Vaccine
- Business owners contend with threat, reality of coronavirus
- Integrated Passive Devices Market revenue to cross USD 2 Billion by 2026: Global Market Insights, Inc.
- Before You Buy Youngevity International, Inc. (NASDAQ:YGYI), Consider Its Volatility
- What Does Success Look Like for a Climate Czar?
- Is Burlington Stores (BURL) a Solid Growth Stock? 3 Reasons to Think Yes
- PRGX Global's (PRGX) Shares March Higher, Can It Continue?
- Outlook into the Worldwide Plasma Protein Therapeutics to 2025 - Featuring CSL Behring, Biotest AG & Baxter Among Others
- Knowles (KN) Q1 Earnings Beat Estimates, Revenues Down Y/Y
- Car rental firm Hertz gets more time from lenders to avoid bankruptcy
- HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Urges Opera Limited (OPRA) Investors With Losses to Contact its Attorneys: Important Class Action Deadline Approaching
- German industrial order rise more than expected in October
- 搜索
-
- 友情链接
-
- BRIEF-A-Rank Announces Bonus Issue Of New Shares
- Cayan to Debut Industry-Changing Solutions at RetailNOW 2016
- Liberty Broadband Corp (LBRDA) Q4 2018 Earnings Conference Call Transcript
- 6 Passengers Fall Ill on Frontier Flight to Tampa from Cleveland
- Alphabet Inc (GOOG) CEO, Google LLC Sundar Pichai Sold $10.2 million of Shares
- Another number paints a bleak picture of manufacturing in China
- BRIEF-Shenji Group Kunming Machine Tool Sees FY Consol Net Loss Attributable RMB251.1 MLN
- Over 900 Retailers Now Accepting Bitcoin Cash
- Eni keeps foot on the gas in high-speed Gulf drive
- Trump says China could have hacked Democratic emails